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Abstract: Efﬁ  cient phagocytosis of cells undergoing apoptosis by macrophages is important to prevent immunological 
responses and development of chronic inﬂ  ammatory disorders such as systemic lupus erythematosus, cystic ﬁ  brosis and 
atherosclerosis. To study phagocytosis of apoptotic cells (AC) by macrophages in tissue, we validated different apoptosis 
markers (DNA fragmentation, caspase-3 activation and cleavage of its substrate poly(ADP-ribose)polymerase-1) in com-
bination with macrophage immunostaining. Human tonsils were used as a model because they show a high apoptosis fre-
quency under physiological conditions as well as efﬁ  cient phagocytosis of AC by macrophages. On the other hand, advanced 
human atherosclerotic plaques were examined since plaques show severely impaired phagocytosis of AC. Our results dem-
onstrate that the presence of non-phagocytized terminal deoxynucleotidyl transferase end labelling (TUNEL)-positive AC 
represents a suitable marker of poor phagocytosis by macrophages in situ. Other markers for apoptosis, such as cleavage of 
caspase-3 or PARP-1, should not be used to assess phagocytosis efﬁ  ciency, because activation of the caspase cascade and 
cleavage of their substrates can occur in AC when they have not yet been phagocytized by macrophages.
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Introduction
Apoptosis or type I programmed cell death is an essential process during morphogenesis, tissue homeo-
stasis and immune regulation and is involved in the elimination of infected, damaged or unwanted cells 
(Wyllie, 1992). The organelles and plasma membrane of apoptotic cells (AC) typically remain intact, 
avoiding proinﬂ  ammatory spilling of the cellular content into the surrounding tissue. In this light, the 
apoptotic process has long been considered immunologically silent. However, recent evidence suggests 
that AC may also contribute to inﬂ  ammatory processes via the release of pro-inﬂ  ammatory cytokines 
(Hogquist et al. 1991) and/or chemotactic factors (Lauber et al. 2003). Moreover, inefﬁ  cient removal 
of AC may lead to induction of postapoptotic necrosis and inﬂ  ammatory responses. To prevent inﬂ  am-
mation, cells signal their apoptotic state at an early stage to their environment, where they are recognized 
and engulfed by phagocytes (Fadok et al. 2001). Surface exposure of phosphatidylserine (PS) is one of 
these “eat-me” signals. To facilitate engulfment, apoptotic cells reduce their volume, contract their 
reorganized cytoskeleton and disintegrate into many small apoptotic bodies. Overall shrinkage is usually 
accompanied by nuclear condensation and internucleosomal DNA-fragmentation. Activation of the 
caspase family of cysteine proteases, in particular caspase-3, seems to be important in the latter process, 
as different caspase-3
-/- cell types, although still susceptible to certain apoptotic stimuli, show a complete 
absence of DNA fragmentation (Woo et al. 1998). Moreover, speciﬁ  c subsets of proteins are cleaved 
by caspase-3 and other executioner caspases to produce the apoptotic phenotype. Among the proteins 
cleaved during apoptosis by caspase-3, poly(ADP-ribose) polymerase-1 (PARP-1) is one of the main 
cleavage targets.
At present, cleavage of caspase-3 and PARP-1 as well as fragmentation of DNA are well known 
biomarkers for apoptosis in tissue. They can be detected either via immunohistochemical techniques 
(cleaved caspase-3 and PARP-1) or via terminal deoxynucleotidyl transferase end labelling (TUNEL) 
of apoptotic cells (DNA fragmentation). Because rapid recognition and clearance of AC by phagocytes 
is essential for normal development and prevention of inﬂ  ammation and disease, phagocytosis of AC 
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by macrophages has been extensively studied in 
chronic inﬂ  ammatory disorders to fully understand 
their pathophysiological role. Accordingly, poor 
phagocytosis of AC has been identiﬁ  ed in patients 
with systemic lupus erythematosis (SLE) (Ren 
et al. 2003), chronic obstructive pulmonary disease 
(COPD) (Hodge et al. 2003), cystic fibrosis 
(Vandivier et al. 2002) and atherosclerosis 
(Schrjvers et al. 2005). However, to interpret clear-
ance of apoptotic cells by phagocytes correctly, 
appropriate detection markers are needed (Nakamura 
et al. 1996). Apoptosis in germinal centers of 
tonsils, as well as in lymph nodes, is a key regula-
tory event to eliminate non- and autoreactive 
lymphocytes. Nearly all AC in germinal centers of 
human tonsils are engulfed by macrophages, 
pointing toward a highly efﬁ  cient recognition and 
elimination process of AC (Baumann et al. 2002). 
Phagocytosis of AC by macrophages in atheroscle-
rotic plaques is severely impaired due to several 
factors, including cytoplasmic saturation, oxidative 
stress and competitive inhibition for common 
epitopes (Schrijvers et al. 2005). In the present 
study, we compared different in situ markers for 
apoptosis (caspase-3 activation, PARP-1 cleavage 
and DNA fragmentation [TUNEL]) to assess the 
efﬁ  ciency of phagocytosis of AC by macrophages 




Human non-inﬂ  amed hyperplastic tonsils (n = 8) 
were obtained from patients (mean age = 28 ± 9 
years, 50% men) undergoing tonsillectomies. 
Human carotid endarterectomy specimens (n = 10) 
were obtained from patients (71 ± 3 years, 70% 
men) with a carotid stenosis of >70%. Specimens 
were ﬁ  xed in 4% formalin within 2 min after 
surgical removal and parafﬁ  n embedded. 
Cell culture
In vitro experiments were performed using the 
murine macrophage cell line J774A.1 and the 
human monocyte cell line U937 (American Type 
Culture Collection). Cells were grown in RPMI 
1640 medium supplemented with 10% fetal bovine 
serum, 100 U/ml penicillin, 100 µg/ml strepto-
mycin, 20 U/ml polymyxin B and 50 µg/ml 
gentamycin. Cell culture media and supplements 
were from Invitrogen, fetal bovine serum was 
purchased from Sigma. To evaluate phagocytosis 
of apoptotic cells in vitro, J774A.1 macrophages 
and U937 cells were co-cultured in RPMI 
containing 50 µM etoposide. Previously, we 
demonstrated that etoposide (Sigma) induces apop-
tosis in U937 cells (77 ± 1% annexin V positive 
AC and complete cleavage of caspase-3 after 4 
hours incubation without induction of necrosis 
(incorporation of propidium iodide)), but not in 
J774A.1 macrophages (Schrijvers et al. 2004). To 
prepare artiﬁ  cial cell blocks, cells were collected 
by scraping and centrifuged (900 × g, 7 min). Three 
drops of ﬁ  brinogen-rich plasma were added to the 
cell pellet. Subsequently, the pellet was detached 
from the tube using a wooden stick and three drops 
of thrombin (100 U/ml) were added. After shaking, 
cells were ﬁ  xed in 6% formol for 1 h. The cell 
pellet was dehydrated using isopropylalcohol and 
toluol and parafﬁ  n embedded.
Flow cytometry
Control and apoptotic U937 cells were stained with 
10 µM of the cell-permeant DNA staining 
compound DRAQ5 (Biostatus Ltd) according to 
manufacturer’s instructions, and subsequently 
analysed by ﬂ  ow cytometry. Cell samples (20,000 
cells/sample) were analyzed on a FACSort cytom-
eter (BD Biosciences). Forward and side scatter 
gates were set to distinguish between viable and 
apoptotic cells. DRAQ5-emitted red ﬂ  uorescence 
was monitored in the FL 3 channel after excitation 
of the probe at 488 nm. Data were analyzed using 
Cell Quest Pro software (BD Biosciences).
Immunohistochemistry 
and terminal deoxynucleotidyl 
transferase end labelling (TUNEL)
Phagocytosis of AC by macrophages was examined 
by an indirect peroxidase antibody conjugate 
method using an anti-CD68 monoclonal antibody 
(clone PG-M1, DAKO) for macrophages, combined 
with an anti-cleaved caspase-3 polyclonal antibody 
(clone 67341A, Pharmingen) or an anti-cleaved 
PARP-1 p85 polyclonal antibody (Promega) to 
detect AC. The monoclonal antibody was detected 
using a goat-anti-mouse peroxidase secondary 
antibody (Jackson) for 45 minutes and visualized 
using Fast Blue as a chromogen. The polyclonal 
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antibodies were detected by a PAP complex. For 
demonstration of the complex, 3-amino-9-ethyl 
carbazole (AEC) was used as a chromogen. Other 
primary antibodies used in this study were: anti-
α-SMC actin (clone 1A4, Sigma), anti-vimentin 
(clone V9, DAKO) and anti-von Willibrand factor 
(The Binding Site Lt). 
For the detection of oligonucleosomal DNA 
cleavage via TUNEL, tissue sections were 
pretreated with proteinase K for 10 minutes at 37°C 
and then rinsed with PBS. Subsequently, sections 
were incubated for 15 minutes at 37°C in a mixture 
containing 25 mM Tris-HCl, 0.25 mg/ml BSA, 200 
mM potassium cacodylate, 5 mM CoCl
2, 270 U/ml 
TdT (Roche), 10 µM dATP (Sigma) and 2.5 µM 
fluorescein-12-dUTP (Roche). Incorporated 
ﬂ  uorescein-dUTP was demonstrated with a sheep 
anti-ﬂ  uorescein peroxidase-conjugated antiserum 
(Boehringer Mannheim) at a dilution of 1/300 for 
45 minutes and visualized by AEC. All TUNEL-
positive AC in whole mount sections of plaques 
(n = 10) were counted and included in the results. 
Because of the high number of cleaved PARP-1 
and cleaved caspase-3 positive AC in plaques, 
labeled cells in ﬁ  ve random regions of interest 
around the necrotic core (120 × 100 µm each) were 
counted. In tonsils (n = 8), ﬁ  ve randomly chosen 
germinal centers were evaluated for phagocytosis 
of AC. AC were considered phagocytized when 
they were surrounded by macrophage cytoplasm. 
Since binding of AC to macrophages not auto-
matically results in uptake, bound cells were 
always considered not ingested.
To colocalize TUNEL with cleaved caspase-3 
immunoreactivity, TUNEL sections were destained 
with 1% hydrochloric acid in 70% ethanol, 
followed by an antigen retrieval method with 
citrate buffer treatment in a microwave oven. The 
sections were then immunostained as described 
above.
Results and Discussion
Human tonsils and atherosclerotic plaques were 
immunostained for CD68, a cell surface marker 
which is present on macrophages, in combination 
with (immuno-) histochemical detection of an in 
situ marker for apoptosis such as cleaved caspase-3, 
cleaved PARP-1 or TUNEL. The number of 
TUNEL-positive AC in whole mount sections of 
carotid plaque specimens amounted to 85 ± 10. In 
addition, numerous cleaved PARP-1 and cleaved 
caspase-3 positive cells were detected (53 ± 3 and 
48 ± 8 per mm
2, respectively). In tonsils, we counted 
per germinal center 17 ± 2 TUNEL-positive AC, 
71 ± 13 cleaved PARP-1 positive AC and 79 ± 8 
cleaved caspase-3 positive AC. Both in tonsils and 
atherosclerotic plaques the majority of cleaved 
caspase-3 and cleaved PARP-1 positive AC were 
located outside but still in close proximity of macro-
phages (Figure 1). TUNEL positive AC in tonsils 
were found almost exclusively inside macrophages 
(Figure 1). However, the majority of TUNEL-
positive AC in atherosclerotic plaques was not 
phagocytized, conﬁ  rming recent data that phago-
cytosis of AC by plaque macrophages is severely 
impaired. In vitro experiments with U937 mono-
cytes undergoing apoptosis after etoposide treat-
ment showed that the majority of apoptotic cells 
(>95%) contain nuclear DNA and thus can be 
detected by TUNEL (Figure 2). We may therefore 
conclude that TUNEL, but not cleaved caspase-3 
and PARP-1, in combination with macrophage 
immunostaining is a suitable method for evaluation 
of phagocytosis of AC by macrophages. 
To reinforce our in situ ﬁ  ndings, co-cultures of 
J774A.1 macrophages and U937 cells (ratio 1:3) 
were treated with etoposide to selectively induce 
U937 apoptosis. After 5 hours, cells were embedded 
in parafﬁ  n, sectioned and immunostained in the 
same way as tissue. Cleaved PARP-1 and caspase-3 
positive AC were not phagocytized by macro-
phages as shown for tissue (Figure 3A,B). 
However, in contrast to apoptotic cells in tonsils 
or atherosclerotic plaques, most TUNEL positive 
U937 cells were not phagocytized by macrophages 
(Figure 3C, arrows). Although this would be 
indicative of poor phagocytosis, preliminary 
experiments showed that phagocytosis should 
occur within the timeframe studied. Moreover, 
etoposide did not affect the phagocytosis capacity 
of the macrophage (data not shown). It is likely 
that the macrophages were overwhelmed by the 
massive induction of apoptosis in U937 cells. 
Indeed, by increasing the ratio of macrophages 
versus AC from 1:3 to 10:1, TUNEL-positive U937 
cells, but not cleaved PARP-1 or caspase-3-positive 
cells, could be readily detected inside macrophages 
(Figure 3D). This limitation should be taken into 
account when studying phagocytosis of AC 
in vitro.
It is important to note that the TUNEL technique 
is easily prone to false positive staining, most 
notably after enhanced transcription (Kockx et al. 
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1998) or during induction of necrotic cell death 
(de Torres et al. 1997; Grasl-Kraupp et al. 1995; 
van Lookeren and Gill, 1996). If results are difﬁ  cult 
to interpret, tissue analysis by electron microscopy 
is recommended to examine morphological 
features of apoptotic cells. Also of note, anti-CD68 
antibodies are not macrophage-speciﬁ  c but may 
crossreact with ﬁ  broblasts and activated endothe-
lial cells (Beranek, 2005; Kunisch et al. 2004). 
Moreover, CD68 is expressed in retinal epithelial 
cells, vascular smooth muscle cells, osteoblasts 
and ﬁ  broblast-like cells from the bone marrow. 
Since cross-reactivity depends on the epitope that 
is recognized by the antibody, stainings patterns 
may differ when using different anti-CD68 clones. 
Anti-CD68 clone PG-M1 used in this study exhibits 
the lowest crossreactivity with other cell types (0% 
of endothelial cells and less than 2% of synovial, 
gingival and skin ﬁ  broblasts) (Kunisch et al. 2004) 
and may therefore be the best choice to identify 
macrophages in different human tissues. To exclude 
nonspeciﬁ  c staining in human plaques and tonsils, 
we identiﬁ  ed CD68 positive cells more thoroughly 
using other cell type speciﬁ  c markers (Figure 4). 
Anti-vimentin antibody, which is commonly used 
to identify ﬁ  broblasts, did not stain CD68 positive 
cells in carotid plaques or tonsil specimens. Similar 
results were obtained with antibodies directed 
against von Willebrand Factor and α-SMC-actin 
which are routinely used for the detection of endo-
thelial cells and smooth muscle cells, respectively. 
It should be noted that during atherogenesis endo-
thelial cells show enhanced vWF deposition (De 
Meyer et al. 1999), which may explain the 
Figure 1. Phagocytosis of apoptotic cells (AC) by macrophages in human tonsils and atherosclerotic plaques. (A) Tissues were immunos-
tained for macrophages (CD68, blue). Apoptotic cells (red-brown) were visualized either via immunohistochemical detection of cleaved 
caspase-3 or cleaved PARP-1, or via TUNEL. Arrowheads show free AC that have not been phagocytized by macrophages, whereas arrows 
indicate uptake of AC by macrophages. Both in tonsils and atherosclerotic plaques the majority of cleaved caspase-3 and cleaved PARP-1 
positive AC were located outside but still in close proximity of macrophages. TUNEL positive AC in tonsils were found almost exclusively 
inside macrophages. In contrast, the majority of TUNEL-positive AC in atherosclerotic plaques was not phagocytized. (B) Quantiﬁ  cation of 
free and phagocytized apoptotic cells in tonsils (grey bars, n = 8) and atherosclerotic plaques (open bars, n = 10). ***p < 0.001 vs tonsils 
(Mann-Whitney U test). Bar = 20 µm.
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additional staining of the subendothelial layer of 
the plaque (Figure 4G). 
Apoptotic DNA degradation, as detected by 
TUNEL, may occur via two different mecha-
nisms: within AC by caspase-activated DNase 
(CAD) and/or within the phagocyte by lysosomal 
DNase II after phagocytosis of AC (Nagata et al. 
2003). Unlike DNase II, DNase I does not play a 
signiﬁ  cant role in apoptotic DNA laddering as 
DNase I
-/- mice do not display altered chromatin 
breakdown during apoptosis (Napirei et al. 2004). 
DNase I is mainly found in body ﬂ  uids such as 
serum and urine. It degrades chromatin in necrotic 
cells and has a main function in breakdown of 
dietary DNA within the alimentary tract (Napirei 
et al. 2004). Colocalization studies indicate that 
only a small fraction of the TUNEL-labeled nuclei 
in tonsils were cleaved caspase-3 positive (data 
not shown). This ﬁ  nding suggests rapid break-
down of cleaved caspase-3 (and probably also 
cleaved PARP-1) by phagosomal pH or lysosomal 
enzymes, once the AC is engulfed by the macro-
phage. On the other hand, TUNEL reactivity of 
AC can be a consequence of engulfment by the 
macrophage and degradation of the genomic DNA 
by DNase II. Both theories support the general 
assumption that TUNEL is the best method to 
detect phagocytosis of AC in situ. Another 
A B
Figure 2. Flow cytometric analysis of etoposide-induced apoptosis in U937 monocytes. Cells were treated with 10 µM etoposide for 0–30 
hours and were then analysed via ﬂ  ow cytometry in the absence (A) or presence (B) of 10 µM DRAQ5. Forward scatter in the X-axis is a 
measure for the size of cells and allowed us to distinguish viable cells from apoptotic bodies (high versus low forward scatter, respectively). 
Each dot plot consists of 4 quadrants representing following populations: DRAQ5 positive apoptotic cells (quadrant 1), DRAQ5 positive vi-
able cells (quadrant 2), DRAQ5 negative apoptotic cells (quadrant 3) and DRAQ5 negative viable cells (quadrant 4). Incubations in the 
absence of DRAQ5 served as negative control for red ﬂ  uorescence. After 30 hours of etoposide treatment, the majority of apoptotic cells 
(>95%) stained positive for DRAQ5 (quadrant 1).
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explanation for the lack of colocalization between 
TUNEL and cleaved caspase-3/PARP-1 immu-
nostaining is the time lag between caspase-3 
activation and CAD-dependent DNA fragmenta-
tion. One may assume that macrophages are able 
to recognize AC in a very early stage of apoptosis 
so that AC are engulfed before DNA fragmenta-
tion occurs. In line with this theory, Denecker 
et al. (2000) demonstrated that cell membrane 
properties that serve as eat-me signals (e.g. expo-
sure of PS) change immediately after initiation 
of apoptosis, thus before cytochrome c release 
and activation of caspases can be detected. 
However, others showed that PS exposure on the 
apoptotic cell is blocked by the pan-caspase 
inhibitor z-VAD-fmk and therefore lies down-
stream from caspase activation. Moreover, these 
ﬁ  ndings are cell culture observations. It remains 
unclear how efﬁ  cient AC are recognized in tissue. 
As yet, we have no evidence for early recognition 
of AC in plaques or tonsils.
In conclusion, unremoved TUNEL-positive AC 
represent a pathological condition and are indica-
tive of poor phagocytosis by macrophages. Other 
markers for apoptosis, such as cleavage of caspase-3 
or PARP-1, should not be used to assess phagocy-
tosis efﬁ  ciency, since activation of the caspase 
cascade and cleavage of their substrates can occur 
in AC when they have not yet been phagocytized 
by macrophages.
Figure 3. In vitro study of phagocytosis of apoptotic U937 cells by J774 macrophages. Macrophages were incubated with U937 cells (ratio 
10:1) in the presence of 50 µM etoposide for 5 hours to allow induction of apoptosis of U937 cells followed by phagocytosis by J774 mac-
rophages. Immunostaining for macrophages (Mac-3, blue) combined with cleaved PARP-1 (A, red), cleaved caspase-3 (B, red) or TUNEL 
(C, red) were performed. Arrowheads indicate free apoptotic cells. Bar = 20 µm. D, Magniﬁ  cation of the boxed area in panel C shows clear 
attachment and uptake of AC by macrophages (arrows). Bar = 10 µm.
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